Compare MRBK & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | KRMD |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.3M | 195.7M |
| IPO Year | 2018 | 2019 |
| Metric | MRBK | KRMD |
|---|---|---|
| Price | $18.95 | $4.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $20.00 | $6.50 |
| AVG Volume (30 Days) | 72.6K | ★ 138.0K |
| Earning Date | 04-24-2026 | 03-12-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | 30.34 | ★ 53.85 |
| EPS | ★ 1.89 | N/A |
| Revenue | $6,316,000.00 | ★ $41,127,366.00 |
| Revenue This Year | $25.40 | $20.32 |
| Revenue Next Year | $8.15 | $17.38 |
| P/E Ratio | $9.98 | ★ N/A |
| Revenue Growth | 10.13 | ★ 22.23 |
| 52 Week Low | $11.17 | $1.87 |
| 52 Week High | $21.03 | $6.61 |
| Indicator | MRBK | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 38.63 |
| Support Level | $18.10 | $4.08 |
| Resistance Level | $19.53 | $4.34 |
| Average True Range (ATR) | 0.64 | 0.21 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 52.48 | 39.29 |
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.